Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7904998rdf:typepubmed:Citationlld:pubmed
pubmed-article:7904998lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:7904998lifeskim:mentionsumls-concept:C0022567lld:lifeskim
pubmed-article:7904998lifeskim:mentionsumls-concept:C1366557lld:lifeskim
pubmed-article:7904998lifeskim:mentionsumls-concept:C1704256lld:lifeskim
pubmed-article:7904998lifeskim:mentionsumls-concept:C0221920lld:lifeskim
pubmed-article:7904998lifeskim:mentionsumls-concept:C0021745lld:lifeskim
pubmed-article:7904998lifeskim:mentionsumls-concept:C0017337lld:lifeskim
pubmed-article:7904998lifeskim:mentionsumls-concept:C0040845lld:lifeskim
pubmed-article:7904998lifeskim:mentionsumls-concept:C0018270lld:lifeskim
pubmed-article:7904998lifeskim:mentionsumls-concept:C2587213lld:lifeskim
pubmed-article:7904998lifeskim:mentionsumls-concept:C0220905lld:lifeskim
pubmed-article:7904998lifeskim:mentionsumls-concept:C0680242lld:lifeskim
pubmed-article:7904998pubmed:issue3lld:pubmed
pubmed-article:7904998pubmed:dateCreated1994-2-25lld:pubmed
pubmed-article:7904998pubmed:abstractTextInterferon gamma (IFN-gamma) is a potent inducer of squamous differentiation in normal human epidermal keratinocytes. This induction is characterized by a > or = 95% decrease in the mRNA level of two growth regulatory genes, cdc2 and E2F-1, and a 7-15-fold increase in the expression of two squamous cell-specific genes, transglutaminase type I and cornifin. In contrast to the decrease in cdc2 and E2F-1 expression, the increase in transglutaminase type I and cornifin mRNAs by IFN-gamma occurs after a lagtime of more than 12 h. These results are consistent with the hypothesis that in normal human epidermal keratinocyte cells irreversible growth arrest precedes the expression of the squamous-differentiated phenotype. The action of IFN-gamma on the expression of squamous cell-specific genes is antagonized by retinoic acid and transforming growth factor beta 1. Both factors are potent suppressors of the induction of transglutaminase type I and cornifin; however, they do not prevent the commitment to irreversible growth arrest. Several squamous cell carcinoma cell lines do not show a detectable decrease in cdc2 or increase in transglutaminase type I mRNA levels after IFN-gamma treatment and appear to be altered in their control of squamous differentiation.lld:pubmed
pubmed-article:7904998pubmed:languageenglld:pubmed
pubmed-article:7904998pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7904998pubmed:citationSubsetIMlld:pubmed
pubmed-article:7904998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7904998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7904998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7904998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7904998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7904998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7904998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7904998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7904998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7904998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7904998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7904998pubmed:statusMEDLINElld:pubmed
pubmed-article:7904998pubmed:monthJanlld:pubmed
pubmed-article:7904998pubmed:issn0021-9258lld:pubmed
pubmed-article:7904998pubmed:authorpubmed-author:JettenA MAMlld:pubmed
pubmed-article:7904998pubmed:authorpubmed-author:SaundersN ANAlld:pubmed
pubmed-article:7904998pubmed:issnTypePrintlld:pubmed
pubmed-article:7904998pubmed:day21lld:pubmed
pubmed-article:7904998pubmed:volume269lld:pubmed
pubmed-article:7904998pubmed:ownerNLMlld:pubmed
pubmed-article:7904998pubmed:authorsCompleteYlld:pubmed
pubmed-article:7904998pubmed:pagination2016-22lld:pubmed
pubmed-article:7904998pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:7904998pubmed:meshHeadingpubmed-meshheading:7904998-...lld:pubmed
pubmed-article:7904998pubmed:meshHeadingpubmed-meshheading:7904998-...lld:pubmed
pubmed-article:7904998pubmed:meshHeadingpubmed-meshheading:7904998-...lld:pubmed
pubmed-article:7904998pubmed:meshHeadingpubmed-meshheading:7904998-...lld:pubmed
pubmed-article:7904998pubmed:meshHeadingpubmed-meshheading:7904998-...lld:pubmed
pubmed-article:7904998pubmed:meshHeadingpubmed-meshheading:7904998-...lld:pubmed
pubmed-article:7904998pubmed:meshHeadingpubmed-meshheading:7904998-...lld:pubmed
pubmed-article:7904998pubmed:meshHeadingpubmed-meshheading:7904998-...lld:pubmed
pubmed-article:7904998pubmed:meshHeadingpubmed-meshheading:7904998-...lld:pubmed
pubmed-article:7904998pubmed:meshHeadingpubmed-meshheading:7904998-...lld:pubmed
pubmed-article:7904998pubmed:meshHeadingpubmed-meshheading:7904998-...lld:pubmed
pubmed-article:7904998pubmed:meshHeadingpubmed-meshheading:7904998-...lld:pubmed
pubmed-article:7904998pubmed:meshHeadingpubmed-meshheading:7904998-...lld:pubmed
pubmed-article:7904998pubmed:meshHeadingpubmed-meshheading:7904998-...lld:pubmed
pubmed-article:7904998pubmed:meshHeadingpubmed-meshheading:7904998-...lld:pubmed
pubmed-article:7904998pubmed:meshHeadingpubmed-meshheading:7904998-...lld:pubmed
pubmed-article:7904998pubmed:meshHeadingpubmed-meshheading:7904998-...lld:pubmed
pubmed-article:7904998pubmed:meshHeadingpubmed-meshheading:7904998-...lld:pubmed
pubmed-article:7904998pubmed:meshHeadingpubmed-meshheading:7904998-...lld:pubmed
pubmed-article:7904998pubmed:meshHeadingpubmed-meshheading:7904998-...lld:pubmed
pubmed-article:7904998pubmed:meshHeadingpubmed-meshheading:7904998-...lld:pubmed
pubmed-article:7904998pubmed:meshHeadingpubmed-meshheading:7904998-...lld:pubmed
pubmed-article:7904998pubmed:meshHeadingpubmed-meshheading:7904998-...lld:pubmed
pubmed-article:7904998pubmed:year1994lld:pubmed
pubmed-article:7904998pubmed:articleTitleControl of growth regulatory and differentiation-specific genes in human epidermal keratinocytes by interferon gamma. Antagonism by retinoic acid and transforming growth factor beta 1.lld:pubmed
pubmed-article:7904998pubmed:affiliationCell Biology Section, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 27709.lld:pubmed
pubmed-article:7904998pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7904998pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7904998lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7904998lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7904998lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7904998lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7904998lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7904998lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7904998lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7904998lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7904998lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7904998lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7904998lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7904998lld:pubmed